Cowden Syndrome and Endometrial Cancer
Before anything else: this is rare. If you have arrived here after reading a list of hereditary cancer syndromes, the overwhelming likelihood is that this one does not apply to you. Cowden syndrome — part of what is now called PTEN hamartoma tumour syndrome — is uncommon, and it is usually recognised through a distinctive combination of non-cancer features rather than through endometrial cancer. Where it is present, breast and thyroid risk dominate the picture, and endometrial cancer is a real but third concern. This page explains what it is, who should be tested, and what surveillance involves.
- Rare, and you probably do not have it — stated plainly at the outset
- Breast and thyroid come first — endometrial risk is real but lower
- Recognised by non-cancer features — head size, skin lesions, thyroid nodules
- Surveillance is organ-specific — and set by a genetics service
on Panel
Across India
Treated
(800+ reviews)
What Cowden Syndrome Involves
The cancers and the benign features together — because in practice it is the benign features that lead to the diagnosis.
| Feature | What it means |
|---|---|
| Breast cancer risk | The dominant concern, with a substantially elevated lifetime risk. Surveillance involves regular clinical examination and imaging from a relatively young age, and risk-reducing mastectomy is discussed as an option for some women. |
| Thyroid cancer risk | The second major concern, and unusual among hereditary syndromes in that it begins in childhood. Regular thyroid ultrasound is part of surveillance from a young age. |
| Endometrial cancer risk | Genuinely elevated, and lower than the breast and thyroid risks. Managed by prompt assessment of abnormal bleeding, sometimes with surveillance, and by discussion of risk-reducing hysterectomy once childbearing is complete. |
| Kidney and bowel cancer risk | Also elevated, and surveillance for both may be included in the plan. Gastrointestinal polyps are common and generally benign. |
| Macrocephaly | A large head circumference, present in almost everyone with the condition and often the feature that first raises the possibility. Measured rather than estimated. |
| Skin and mouth lesions | Small bumps on the face and hands, and cobblestone-like changes inside the mouth. Benign, characteristic, and frequently long-standing before anyone connects them to anything. |
| Benign thyroid disease | Multiple nodules and goitre are common and usually benign. Their presence contributes to the clinical picture rather than indicating cancer. |
The syndrome is diagnosed by genetic testing, not by feature-counting at home. Clinical criteria exist and are used by genetics services to decide who to test. Recognising one or two features in yourself is not a diagnosis, and the right next step is a referral rather than a conclusion.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Who Should Be Referred for Testing
Genetics services use formal criteria. Broadly, referral becomes appropriate when several of these are present together.
- A combination of the characteristic features. Macrocephaly together with the typical skin or oral lesions, particularly alongside breast or thyroid disease, is the classic pattern that prompts referral.
- Breast or thyroid cancer at a young age. Especially where it coexists with the benign features above, or where more than one of these cancers has occurred in the same person.
- A close relative with a confirmed PTEN variant. The clearest indication of all. Each first-degree relative has a one in two chance of carrying the same variant, and predictive testing is straightforward once the family variant is known.
- Multiple hamartomas across different organs. Benign overgrowths in skin, thyroid, breast, bowel and uterus occurring together is the underlying signature of the condition.
- Endometrial cancer at a young age with other features. Endometrial cancer alone does not prompt PTEN testing — Lynch syndrome is the far commoner hereditary cause and is what current practice screens all endometrial tumours for. See MMR and MSI testing.
Testing should follow genetic counselling rather than precede it, because the implications of a positive, negative or uncertain result — for you and for your relatives — are worth understanding before the sample is taken. See genetic counselling.
Want to Know Whether Testing Is Warranted?
A proper family history assessment, and genetic counselling before any test is done.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Lynch Is Far More Likely Than Cowden
For a woman with endometrial cancer and a family history, Lynch syndrome is the common hereditary cause — and it is already tested for.
If a PTEN Variant Is Confirmed
Surveillance is organised by organ and set by a genetics service. What follows describes its shape rather than prescribing a schedule.
- Breast surveillance from a young age. Regular clinical examination and imaging, starting considerably earlier than population screening. Risk-reducing mastectomy is discussed as an option rather than presented as expected.
- Thyroid ultrasound, starting in childhood. Unusual among hereditary cancer syndromes and important, since thyroid cancer in this condition can occur young.
- Attention to abnormal bleeding. The main gynaecological measure. Endometrial surveillance may be offered; the more valuable step is that any abnormal bleeding is assessed promptly rather than watched. See endometrial biopsy.
- Kidney and bowel surveillance. Included in the plan for many carriers, with intervals set by the genetics team.
- Discussion of risk-reducing hysterectomy. Once childbearing is complete, this becomes a reasonable conversation for the gynaecological risk — a discussion rather than a recommendation, and one that weighs surgery against surveillance. See risk-reducing surgery.
As with Lynch syndrome, testing relatives is part of the plan rather than an optional extra. Each first-degree relative has a one in two chance of carrying the variant, and those who do gain access to surveillance. See testing your family.
Want Your Family History Properly Assessed?
Formal criteria applied by people who use them daily. Most women are reassured. The opinion is free.
Keeping This in Proportion
Five things worth holding on to if reading this page has unsettled you.
This is genuinely rare
Cowden syndrome is uncommon, and the overwhelming majority of women with endometrial cancer — including those with a family history of it — do not have it. If a hereditary cause is present at all, Lynch syndrome is far and away the more likely one, and it is already tested for in current practice.
A large head is not a diagnosis
Macrocephaly is present in almost everyone with the syndrome, which is not at all the same as saying that everyone with a large head circumference has the syndrome. Head size varies widely and normally. It is the combination of features that carries meaning, and that combination is assessed by a genetics service.
Skin lesions are extremely common in general
Small skin-coloured bumps on the face and hands are ordinary and are usually nothing. Their significance in this context comes entirely from occurring alongside other features, not from existing at all.
Thyroid nodules are common and usually benign
A large proportion of adults have thyroid nodules, and the great majority are benign. Finding one on a scan is not evidence of an inherited syndrome and does not by itself warrant genetic testing.
A genetics service will tell you plainly
The value of a referral is not that it always finds something. It is that the family history is assessed against formal criteria by people who do it constantly, and most women who are referred are told the criteria are not met. That is a useful outcome. See is endometrial cancer hereditary.
Why a Genetics Service Rather Than a Checklist
Feature lists read alarmingly. Formal criteria applied by a genetics team usually read reassuringly.
Lynch counselling built in
45-minute consultations
Named MCh surgical oncologists
Tumour board for every diagnosis
One place for the whole pathway
Costs explained before you commit
Rare Means Rare
If a hereditary cause is present at all, Lynch syndrome is far more likely — and it is already tested for.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Cowden Syndrome — Frequently Asked Questions
What is Cowden syndrome?
A rare inherited condition caused by a fault in the PTEN gene, and part of what is now called PTEN hamartoma tumour syndrome. It causes multiple benign overgrowths — hamartomas — in the skin, mouth, thyroid, breast, bowel and uterus, and increases the lifetime risk of breast, thyroid, endometrial, kidney and bowel cancer. Breast and thyroid risk dominate the picture; endometrial cancer risk is real but lower. It is inherited in a dominant pattern, so each first-degree relative of a carrier has a one in two chance of carrying the same variant. It is uncommon, and it is confirmed by genetic testing rather than by clinical impression.
How would I know if I might have it?
It is usually recognised through a combination of features rather than any single one. A larger than average head circumference is present in almost everyone with the condition. Characteristic small skin-coloured bumps on the face and hands, and cobblestone-like lesions inside the mouth, are typical, as are multiple benign thyroid nodules and gastrointestinal polyps. What prompts a genetics referral is these features occurring together, particularly alongside breast or thyroid cancer at a young age in you or your family. Recognising one or two features in yourself is not a diagnosis — formal criteria exist and are applied by genetics services.
I have endometrial cancer. Should I be tested for PTEN?
Not on the basis of the endometrial cancer alone. Lynch syndrome is by far the commoner hereditary cause of endometrial cancer, and current practice already screens tumours for mismatch repair deficiency in every case, which is the first step towards identifying it. PTEN testing becomes appropriate where the clinical picture suggests Cowden syndrome — the characteristic features together, breast or thyroid cancer at a young age, multiple hamartomas across organs, or a known PTEN variant in the family. A genetics service will assess which, if either, applies to you.
What surveillance is recommended if I carry a PTEN variant?
Surveillance is organised by organ and set by a genetics service rather than being uniform. Breast surveillance with regular examination and imaging starts considerably earlier than population screening, and risk-reducing mastectomy is discussed as an option. Thyroid ultrasound begins in childhood, which is unusual among hereditary cancer syndromes and reflects that thyroid cancer here can occur young. Kidney and bowel surveillance are included for many carriers. For the uterus, the central measure is prompt assessment of any abnormal bleeding, with endometrial surveillance sometimes offered and risk-reducing hysterectomy discussed once childbearing is complete.
If I have it, what does it mean for my children?
It is inherited in an autosomal dominant pattern, which means each child has a one in two chance of inheriting the same variant, independent of the others. Once the family variant is known, predictive testing for relatives is straightforward, and those who carry it can enter surveillance while those who do not can be reassured and discharged. Because thyroid surveillance in this condition begins in childhood, testing of children is a genuine consideration rather than something to defer to adulthood — but the timing is a decision to make with a genetics service, which will also help with how to raise it in the family.
Medical disclaimer: This page provides general information about Cowden syndrome and endometrial cancer risk, reviewed by a CION oncologist. It is not a substitute for genetic counselling or individual medical advice. Cowden syndrome is rare and is diagnosed by genetic testing following assessment against formal clinical criteria; recognising individual features described here does not constitute a diagnosis. Genetic testing should be preceded by counselling covering the implications for you and your relatives.